Search Results - "Clain, Jonathan E."

Differences in Clinical Profile and Relapse Rate of Type 1 Versus Type 2 Autoimmune Pancreatitis by Sah, Raghuwansh P, Chari, Suresh T, Pannala, Rahul, Sugumar, Aravind, Clain, Jonathan E, Levy, Michael J, Pearson, Randall K, Smyrk, Thomas C, Petersen, Bret T, Topazian, Mark D, Takahashi, Naoki, Farnell, Michael B, Vege, Santhi S

“…Background & Aims Autoimmune pancreatitis (AIP) has been divided into subtypes 1 (lymphoplasmacytic sclerosing pancreatitis) and 2 (idiopathic duct centric…”
Get full text

Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience by Chari, Suresh T, Smyrk, Thomas C, Levy, Michael J, Topazian, Mark D, Takahashi, Naoki, Zhang, Lizhi, Clain, Jonathan E, Pearson, Randall K, Petersen, Bret T, Vege, Santhi Swaroop, Farnell, Michael B

“…The Japan Pancreas Society criteria for diagnosis of autoimmune pancreatitis (AIP) mandate presence of characteristic imaging (diffuse pancreatic enlargement…”
Get more information

Immunoglobulin G4–Associated Cholangitis: Clinical Profile and Response to Therapy by Ghazale, Amaar, Chari, Suresh T, Zhang, Lizhi, Smyrk, Thomas C, Takahashi, Naoki, Levy, Michael J, Topazian, Mark D, Clain, Jonathan E, Pearson, Randall K, Petersen, Bret T, Vege, Santhi Swaroop, Lindor, Keith, Farnell, Michael B

“…Background & Aims: Immunoglobulin (Ig)G4-associated cholangitis (IAC) is the biliary manifestation of a steroid-responsive multisystem fibroinflammatory…”
Get full text

A Diagnostic Strategy to Distinguish Autoimmune Pancreatitis From Pancreatic Cancer by Chari, Suresh T, Takahashi, Naoki, Levy, Michael J, Smyrk, Thomas C, Clain, Jonathan E, Pearson, Randall K, Petersen, Bret T, Topazian, Mark A, Vege, Santhi S

“…Background & Aims Autoimmune pancreatitis (AIP) and pancreatic cancer (PaC) have similar presentations; a diagnostic strategy is needed to distinguish the 2…”
Get full text

Clinical profiles and outcomes in idiopathic duct-centric chronic pancreatitis (type 2 autoimmune pancreatitis): the Mayo Clinic experience by Hart, Phil A, Levy, Michael J, Smyrk, Thomas C, Takahashi, Naoki, Abu Dayyeh, Barham K, Clain, Jonathan E, Gleeson, Ferga C, Pearson, Randall K, Petersen, Bret T, Topazian, Mark D, Vege, Santhi S, Zhang, Lizhi, Chari, Suresh T

“…Idiopathic duct-centric chronic pancreatitis (IDCP), also known as type 2 autoimmune pancreatitis (AIP), is an uncommon subtype of AIP. International Consensus…”
Get more information

Diagnostic performance of cyst fluid carcinoembryonic antigen and amylase in histologically confirmed pancreatic cysts by Park, Walter Gwang-Up, Mascarenhas, Ranjan, Palaez-Luna, Mario, Smyrk, Thomas C, O'Kane, Dennis, Clain, Jonathan E, Levy, Michael J, Pearson, Randall K, Petersen, Bret T, Topazian, Mark D, Vege, Santhi S, Chari, Suresh T

“…The objective of this study was to evaluate and validate cyst fluid carcinoembyronic antigen (CEA) and amylase in differentiating (1) nonmucinous from mucinous…”
Get full text

EUS-guided ethanol lavage does not reliably ablate pancreatic cystic neoplasms (with video) by Gómez, Victoria, MD, Takahashi, Naoki, MD, Levy, Michael J., MD, McGee, Kiaran P., PhD, Jones, Andrea, MD, Huang, Yajue, MD, PhD, Chari, Suresh T., MD, Clain, Jonathan E., MD, Gleeson, Ferga C., MBBCh, Pearson, Randall K., MD, Petersen, Bret T., MD, Rajan, Elizabeth, MD, Vege, Santhi Swaroop, MD, Topazian, Mark D., MD

“…Background The true efficacy of EUS-guided ethanol lavage (EEL) of pancreatic cystic neoplasms is unclear. This study aimed to assess long-term outcomes and…”
Get full text

Histologic and Imaging Features of Mural Nodules in Mucinous Pancreatic Cysts by Zhong, Ning, Zhang, Lizhi, Takahashi, Naoki, Shalmiyev, Vladislav, Canto, Marcia Irene, Clain, Jonathan E, Deutsch, John C, DeWitt, John, Eloubeidi, Mohamad A, Gleeson, Ferga C, Levy, Michael J, Mallery, Shawn, Raimondo, Massimo, Rajan, Elizabeth, Stevens, Tyler, Topazian, Mark

“…Background & Aims Mural nodules predict malignancy within pancreatic cysts, but it is not clear whether endoscopic ultrasound (EUS) and computed tomography…”
Get full text

Low Mortality and High Morbidity in Severe Acute Pancreatitis Without Organ Failure: A Case for Revising the Atlanta Classification to Include "Moderately Severe Acute Pancreatitis" by SWAROOP VEGE, Santhi, GARDNER, Timothy B, CHARI, Suresh T, MUNUKUTI, Padma, PEARSON, Randall K, CLAIN, Jonathan E, PETERSEN, Bret T, BARON, Todd H, FARNELL, Michael B, SARR, Michael G

“…Organ failure (OF) is a main cause of death in severe acute pancreatitis (SAP). Our primary aim was to evaluate the morbidity and mortality of patients…”
Get full text

Do Consensus Indications for Resection in Branch Duct Intraductal Papillary Mucinous Neoplasm Predict Malignancy? A Study of 147 Patients by PELAEZ-LUNA, Mario, CHARI, Suresh T, KENDRICK, Michael, FARNELL, Michael B, SMYRK, Thomas C, TAKAHASHI, Naoki, CLAIN, Jonathan E, LEVY, Michael J, PEARSON, Randall K, PETERSEN, Bret T, TOPAZIAN, Mark D, VEGE, Santhi S

“…Recent consensus guidelines suggest that presence of > or =1 of the following is an indication for resection (IR) of branch duct intraductal papillary mucinous…”
Get full text

Disconnected pancreatic duct syndrome in severe acute pancreatitis: clinical and imaging characteristics and outcomes in a cohort of 31 cases by Pelaez-Luna, Mario, MD, Vege, Santhi Swaroop, MD, Petersen, Bret T., MD, Chari, Suresh T., MD, Clain, Jonathan E., MD, Levy, Michael J., MD, Pearson, Randal K., MD, Topazian, Mark D., MD, Farnell, Michael B., MD, Kendrick, Michael L., MD, Baron, Todd H., MD

“…Background Information regarding the natural history, clinical characteristics, and outcomes of disconnected pancreatic duct syndrome (DPDS) is limited…”
Get full text

Impact of celiac neurolysis on survival in patients with pancreatic cancer by Fujii-Lau, Larissa L., MD, Bamlet, William R., MD, Eldrige, Jason S., MD, Chari, Suresh T., MD, Gleeson, Ferga C., MD, Abu Dayyeh, Barham K., MD, Clain, Jonathan E., MD, Pearson, Randall K., MD, Petersen, Bret T., MD, Rajan, Elizabeth, MD, Topazian, Mark D., MD, Vege, Santhi S., MD, Wang, Kenneth K., MD, Wiersema, Maurits J., MD, Levy, Michael J., MD

“…Background Pancreatic cancer (PC) often produces pain that is difficult to control. Celiac neurolysis (CN) is performed with the goal of improving pain control…”
Get full text

Initial Evaluation of the Efficacy and Safety of Endoscopic Ultrasound-Guided Direct Ganglia Neurolysis and Block by LEVY, Michael J, TOPAZIAN, Mark D, PETERSEN, Bret T, VEGE, Santhi S, CHARI, Suresh T, WIERSEMA, Maurits J, CLAIN, Jonathan E, RAJAN, Elizabeth, WANG, Kenneth K, DE LA MORA, Jose G, GLEESON, Ferga C, PEARSON, Randall K, PELAEZ, Mario C

“…Celiac plexus neurolysis and block are considered safe but provide limited pain relief. Standard techniques target the region of the celiac plexus but do not…”
Get full text

Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas by Chari, Suresh T., Yadav, Dhiraj, Smyrk, Thomas C., DiMagno, Eugene P., Miller, Laurence J., Raimondo, Massimo, Clain, Jonathan E., Norton, Ian A., Pearson, Randall K., Petersen, Bret T., Wiersema, Maurits J., Farnell, Michael B., Sarr, Michael G.

“…Background & Aims: The aim of this study was to determine recurrence and long-term survival after resection of pancreatic intraductal papillary mucinous…”
Get full text

Utility of EUS in the evaluation of cystic pancreatic lesions by Sedlack, Robert, Affi, Aboud, Vazquez-Sequeiros, Enrique, Norton, Ian D., Clain, Jonathan E., Wiersema, Maurits J.

“…Background: Preoperative differentiation of benign and malignant/potentially malignant pancreatic cystic lesions is problematic. Data to support the role of…”
Get full text

EUS-guided FNA of regional lymph nodes in patients with unresectable hilar cholangiocarcinoma by Gleeson, Ferga C., MD, Rajan, Elizabeth, MD, Levy, Michael J., MD, Clain, Jonathan E., MD, Topazian, Mark D., MD, Harewood, Gavin C., MD, Papachristou, Georgios I., MD, Takahashi, Naoki, MD, Rosen, Charles B., MD, Gores, Gregory J., MD

“…Background The clinical impact of EUS-guided FNA (EUS-FNA) in regional lymph-node staging in patients with unresectable hilar cholangiocarcinoma before liver…”
Get full text

EUS-derived criteria for distinguishing benign from malignant metastatic solid hepatic masses by Fujii-Lau, Larissa L., MD, Abu Dayyeh, Barham K., MPH, MD, Bruno, Marco J., MD, Chang, Kenneth J., MD, DeWitt, John M., MD, Fockens, Paul, MD, Forcione, David, MD, Napoleon, Bertrand, MD, Palazzo, Laurent, MD, Topazian, Mark D., MD, Wiersema, Maurits J., MD, Chak, Amitabh, MD, Clain, Jonathan E., MD, Faigel, Douglas O., MD, Gleeson, Ferga C., MD, Hawes, Robert, MD, Iyer, Prasad G., MD, Rajan, Elizabeth, MD, Stevens, Tyler, MD, Wallace, Michael B., MD, Wang, Kenneth K., MD, Levy, Michael J., MD

“…Background Detection of hepatic metastases during EUS is an important component of tumor staging. Objective To describe our experience with EUS-guided FNA…”
Get full text

Detection of peritoneal carcinomatosis by EUS fine-needle aspiration: impact on staging and resectability (with videos) by Levy, Michael J., MD, Abu Dayyeh, Barham K., MD, MPH, Fujii, Larissa L., MD, Clayton, Amy C., MD, Reynolds, Jordan P., MD, Lopes, Tercio L., MD, Rao, Archana S., MD, Clain, Jonathan E., MD, Gleeson, Ferga C., MD, Iyer, Prasad G., MD, Kendrick, Michael L., MD, Rajan, Elizabeth, MD, Topazian, Mark D., MD, Wang, Kenneth K., MD, Wiersema, Maurits J., MD, Chari, Suresh T., MD

“…Background Peritoneal carcinomatosis (PC) greatly affects cancer staging and resectability. Objective To compare the PC detection rate by using EUS and…”
Get full text

Faster Rate of Initial Fluid Resuscitation in Severe Acute Pancreatitis Diminishes In-Hospital Mortality by Gardner, Timothy B, Vege, Santhi Swaroop, Chari, Suresh T, Petersen, Bret T, Topazian, Mark D, Clain, Jonathan E, Pearson, Randall K, Levy, Michael J, Sarr, Michael G

“…Abstract Background/Aims: We evaluated the impact of the initial intravenous fluid resuscitation rate within the first 24 h of presentation to the emergency…”
Get full text

Prospective evaluation of adverse events following lower gastrointestinal tract EUS FNA by Levy, Michael J, Abu Dayyeh, Barham K, Fujii, Larissa L, Boardman, Lisa A, Clain, Jonathan E, Iyer, Prasad G, Rajan, Elizabeth, Topazian, Mark D, Wang, Kenneth K, Wiersema, Maurits J, Gleeson, Ferga C

“…There are virtually no data concerning the risk of adverse events (AEs) following lower gastrointestinal (LGI) endoscopic ultrasound (EUS). Our aim was to…”
Get full text